Table 2. Comparisons of participants (n = 1,157) and nonparticipants (n = 3,411) of the 6-month follow-up; n (%); mean [SD].
Participants n = 1,157+ | Nonparticipants n = 3,411+ | p | |
Interest in psychotherapy | 193 (16.7) | 336 (9.9) | <0.001 |
Age: Years | 52.49 [15.53] | 45.75 [16.02] | <0.001 |
Women | 667 (57.6) | 1708 (50.1) | <0.001 |
Partnership status: Living with a partner | 768 (67.1) | 2051 (60.8) | <0.001 |
Level of education: University entrance qualification | 511 (44.6) | 1374 (40.5) | 0.015 |
ASA Classification++a) | <0.001 | ||
ASA I | 172 (24.1) | 773 (34.1) | |
ASA II | 416 (58.2) | 1218 (53.8) | |
ASA III | 125 (17.5) | 270 (11.9) | |
ASA IV | 2 (0.3) | 5 (0.2) | |
Surgical field ++ | 0.028 | ||
Abdomino thoracic surgery | 283 (39.6) | 868 (38.3) | |
Peripheral surgery | 235 (32.9) | 660 (29.1) | |
Neuro-, head and neck surgery | 197 (27.6) | 738 (32.6) | |
BSI GSI, severity of psychological distress b) | 0.34 [0.37] | 0.33 [0.39] | 0.168 |
Self-rating of current subjective health c) | 64.31 [24.78] | 64.22 [27.49] | 0.917 |
WHO-5 d) | 14.54 [5.83] | 14.44 [5.79] | 0.587 |
PHQ-2 e) | 1.48 [1.44] | 1.40 [1.40] | 0.094 |
CES-D f) | 9.98 [6.90] | 9.56 [6.56] | 0.078 |
BSI depression b) | 0.32 [0.53] | 0.30 [0.52] | 0.377 |
GAD-2 g) | 1.35 [1.51] | 1.23 [1.41] | 0.013 |
BSI anxiety b) | 0.39 [0.47] | 0.35 [0.47] | 0.008 |
BSI interpersonal sensitivity b) | 0.35 [0.53] | 0.34 [0.53] | 0.347 |
BSI phobic anxiety b) | 0.18 [0.38] | 0.17 [0.37] | 0.544 |
AUDIT sum score h) | 2.79 [3.15] | 3.09 [3.52] | 0.007 |
AUDIT-C: Risky alcohol consumption h) | 2.34 [1.96] | 2.50 [2.13] | 0.015 |
Number ranges for the specific variables from 1,123 to 1,157 (participants) and from 3,236 to 3,411 (nonparticipants) because of missing data.
Data for ASA and surgical field are available for the implementation phase; numbers account to 715 (participants), and 2266 (nonparticipants) because of missing data.
ASA (American Society of Anesthesiologists) physical status classification: (I) Healthy patient; (II) Mild systemic disease, no functional limitation; (III) Severe systemic disease with definite functional limitation; (IV) Severe systemic disease that is a constant threat to life;
BSI: Brief Symptom Inventory; GSI: General severity index;
Visual analogue scale of the EQ-5D, 0 to 100 with higher scores indicating better subjective health;
WHO-5: World Health Organization 5-item Well-Being Index;
PHQ-2: Patient Health Questionnaire-4, depression subscale;
CES-D: Center for Epidemiologic Studies Depression Scale;
GAD-2: Patient Health Questionnaire-4, anxiety subscale;
AUDIT: Alcohol Use Disorder Identification Test, AUDIT-C: AUDIT subscore for risky alcohol consumption.